The successful cure of about 60% of children with STS has focused attention on the identification of those who fail therapy and on the late effects of successful treatment. In RMS, which accounts for approximately 60% of all STSs, certain clinical and pathological characteristics have been related to prognosis with varying consistency, of which the most important are tumour site, stage and histological subtype (Rodary et al., 1991) . More accurate identification at or soon after diagnosis of individuals who are at high risk of treatment failure would allow therapy to be intensified in a selected group of patients. Conversely, the identification of patients with a very good prognosis may allow the intensity of therapy to be reduced, decreasing the risk of long-term toxicity. It is likely that exploration of their biological characteristics will emphasise the heterogeneous nature of tumours which, by conventional criteria, may seem to have a similar chance of successful treatment. The evaluation of ploidy, chromosomal abnormalities, oncogene amplification and multidrug resistance phenotype are examples of such an approach (Anonymous, 1989) .
Measurement of cellular DNA content has become increasingly common. The relationship between abnormalities in DNA content or proliferative characteristics and prognosis has been explored for a variety of malignancies (Merkel et al., 1987) , particularly as methods for applying these techniques to formalin-embedded tissue have been established (Hedley et al., 1983) . Nevertheless, there are very few reports of this in childhood soft-tissue sarcoma, and the results are not consistent. While some authors suggest a better response to chemotherapy in aneuploid (Boyle et al., 1988; Molenaar et al., 1988) or hyperdiploid RMSs (Shapiro et al., 1991) compared with their diploid counterparts, others could not confirm an association of ploidy with survival in this tumour category (Kowal-Vern et al., 1990; Leuschner et al., 1991; Dias et al., 1992) .
In this report we investigate the value of DNA measurement and proliferative activity in childhood STSs in a retrospective study using formalin-fixed and paraffin-embedded tumour specimens. (Rodary et al., 1989 (Ragab et al., 1992; Maurer et al., 1993) , and since then according to the SIOP MMT-89 strategy (Stevens et al., 1991) .
In addition we investigated a selected group of seven children with alveolar RMS treated at the Royal Marsden Hospital, Sutton, Surrey, UK, in order to increase the numbers of patients available for analysis in this subgroup, which was underrepresented in the above series.
Cytometric investigations included measurement of ploidy (DNA index) and proliferation activity (S-phase). Represen used as an index of proliferative activity of the tumour. The S-phase fraction was calculated with the model of multiple broadened rectangles or dual cycling populations (Baish et al., 1982; Scott et al., 1992) . Flow cytometric analysis disclosed the presence of four distinct categories of cellular DNA content (Figure 1 ). The presence of a single GO/GI peak indicated a diploid tumour.
A DNA index (DI) of 1.0 referred to a diploid cell line, between 1.0 and 1.09 was called 'near-diploid' and the term 'hyperdiploid' was used to characterise cell populations with a DI between 1.10 and 1.80. 'Tetraploid' denoted a cell population with a DNA index between 1.81 and 2.20. A fifth category, 'hypertetraploid', has been used in the literature to describe tumours with a DNA index above 2.20, but since only two hypertetraploid cases were found in this series, they have been included in the tetraploid category. For the purpose of analyses the diploid and near-diploid categories were combined.
The prognostic value of clinical parameters and flow cytometric parameters (DI and S-phase) was investigated using univariate methods, namely the log-rank test, and by multivariate methods using a stepwise Cox's proportional hazards model. Differences in median S-phase were investigated with the Kruskal-Wallis test, and the chi-square test was used to assess differences in ploidy.
Results
Five year actuarial survival in this series was 63.4% for all STSs and 69.4% for RMSs. Distributions of tumour histology, ploidy pattern and S-phase are shown in Table I .
There were significant differences in DNA content and proliferative activity (S-phase) between the three major histological categories of STS. Sixty-six per cent (40/61) of RMSs were aneuploid (DNA index >1.10) compared with 23% (3/13) of the EOE/PNET and 31% (5/16) of the non-RMS STSs (P = 0.003). Eighteen per cent (2/11) of alveolar RMSs were tetraploid compared with 12% (6/50) of embryonal RMSs. The frequency distribution of DNA indices in the different subtypes is shown in Figure 2 . Whereas the DNA content of the embryonal RMSs was distributed over the whole range of hyperdiploidy and tetraploidy, only 1 (a Five year survival rate in hyperdiploid RMS (DI 1.10-1.79) was 88.3% compared with 28.6% in tetraploid (DI > 1.80), 44.4% in near-diploid (DI 1.0-1.09) and 58.3% in diploid tumours (P=0.0003). Since there was no significant difference between diploid and near-diploid tumours, these two categories were combined (5 year survival 54.6%). Ninety-five per cent of children with an RMS and an S-phase below 14% were alive after 5 years compared with 50% with an S-phase above 14%. In the univariate analysis not only did tetraploid RMS have a significantly decreased survival compared with the hyperdiploid tumours, but also the outcome of the diploid/near-diploid category was significantly worse (P = 0.0054).
Multivariate analysis (Table III) could be performed on 59 cases with complete data and revealed that stage IV disease, tetraploidy, diploidy/near diploidy and S-phase (> 14%) were independently associated with significantly poorer survival. The threshold at 14% was selected by the stepwise analysis as the most discriminating variable.
When the analysis was repeated using only non-metastatic patients (stage I-III, 48 cases), hyperdiploidy was even more significant (relative hazard 12.24) and S-phase remained an independent prognostic indicator. n ju -mm., mj m recognised that in subgroups of ALL (Look et al., 1985) and neuroblastoma (Look et al., 1984; Huddart et al., 1992) , hyperdiploid tumour stem lines seem to favour prognosis compared with their diploid or tetraploid counterparts, whereas this prognostic feature seems to be reversed in Wilms' tumour and most adult tumours (Douglass et al., 1986; Schmidt et al., 1986; Merkel et al., 1987; Barrantes et al., 1993) . Data from other tumours such as medulloblastoma and hepatoblastoma are conflicting (Yasue et al., 1989; Hata et al., 1991; Zerbini et al., 1993) . There are only a few reports on the prognostic implication of DNA content in childhood STS and the results are not consistent (Boyle et al., 1988; Molenaar et al., 1988; Kowal-Vern et al., 1990; Leuschner et al., 1991; Shapiro et al., 1991; Dias et al., 1992) . The results in this study, so far the largest series evaluating this tumour group, confirm that ploidy has a significant and independent impact on outcome in rhabdomyosarcoma. Although stage IV disease is the most powerful predictor of outcome, tetraploidy/hypertetraploidy is strongly associated with an unfavourable prognosis, whereas hyperdiploidy (DI 1.10-1.80) is usually associated with a better outcome. The prognostic significance of the ploidy pattern was even more apparent in non-peripheral metastatic cases. In the univariate analysis diploid/near-diploid RMSs were associated with a significantly decreased survival compared with the hyperdiploid tumours. These results are similar to those of a study in St. Jude Children's Hospital (Shapiro et al., 1991) and of the Intergroup Rhabdomyosarcoma Study (Pappo et al., 1993) , which found that hyperdiploidy also predicted a significantly favourable prognosis compared with diploidy/near diploidy. Similarly, tetraploidy was more often found in the alveolar subtype. We looked at four additional alveolar RMSs that were not included in this study because of age > 16 years and found that three of them showed also tetraploidy, which increases the number with tetraploidy within the alveolar subtype to 33% compared with 12% in the embryonal RMSs. The discrepancies between these findings and those of some other studies (Leuschner et al., 1991; Dias et al., 1992) , in which no correlation between DNA ploidy and overall survival could be found, may be explained by several factors: sample size, pathological classification, age distribution, flow cytometric analysis and precise ploidy definition.
In many studies, the definition of DNA ploidy does not extend beyond 'DNA diploid' and 'DNA aneuploid', and this pooling may mask the prognostic effect of different aneuploid types. This study suggests that there may be three distinct biological subtypes of RMS with different prognoses, namely diploid/near-diploid (DI = 1.0-1.09), hyperdiploid (DI = 1.10-1.80) and tetraploid/hypertetraploid (DI > 1.80). In neuroblastoma it has been suggested that evolution of the tetraploid karyotype differs from the hyperdiploid, the former being caused by an endoreduplication from a primary diploid or near-diploid cell line (Kaneko et al., 1987) . A similar mechanism may be involved in RMS, as is suggested by our unpublished observations. Flow cytometric measurement of formalin-fixed and paraffin-embedded tissue does, however, have its limitations and pitfalls. The intensity of the fluorochrome staining is dependent on the use of enzymes to break down covalent linkages between DNA and nuclear proteins caused by fixation (Hedley et al., 1983) , and the completeness of the digestive process in each sample may be difficult to gauge. Hence, the absolute fluorescence of the diploid populations can vary significantly from block to block, which precludes the use of external standards. Furthermore, hypodiploid cell populations cannot be distinguished in paraffin sections, but are assumed to be very rare. Nevertheless, several groups which have compared flow cytometric profiles from fresh and paraffin-embedded tissue (Hedley et al., 1983; Frierson, 1988; Kallioniemi, 1988) have found a good correlation for the DNA index. Although a minor loss of quality in archival samples cannot be denied, and the techniques for preparing the sample may have to be tailored for different tissue groups, paraffin-embedded tissues are a convenient and reasonably accurate subject for DNA ploidy. Of more concern is the variation in DNA ploidy that may occur in different samples of the same tumour. Intra-tumour variation in DNA ploidy is reported in the literature in up to 25% of some tumour types (Kallioniemi, 1988) , and recently heterogeneity of DNA content was also reported in some RMSs (Dominici et al., 1993) . Multiple sampling for DI measurement is therefore recommended.
In several studies of adult malignancies, proliferative activity (S-phase) has been shown to be more powerful in predicting outcome than DNA index (Herman, 1992) . However, major problems in estimating the S-phase are the overlap with normal host cells and the fact that the accuracy of the estimates is considerably reduced by large amounts of cell debris, especially in paraffin-embedded material. Comparisons of S-phase between different studies must be undertaken with caution since there are different models available for analysing the proliferative activity, and the measurement is also dependent on the computer software used. Nevertheless, in our population, we were able to demonstrate that S-phase had a significant impact on survival: only 1/24 children with RMS and an S-phase <14% died in this cohort of patients. If problems of accurately measuring the cell proliferative activity can be overcome, S-phase may become a useful prognostic factor with clinical significance.
The number of cases of non-rhabdomyosarcomatous softtissue sarcoma in this study was too small to allow firm conclusions to be made. Nevertheless Ewing's/PNET and other non-RMS STSs appear to have a different ploidy pattern and a significantly lower DNA index and proliferative activity than RMS. According to our results and a recent study of 19 patients with PNET (Swanson et al., 1992) there is insufficient evidence that ploidy pattern may predict outcome in these rarer diagnoses.
We conclude that DNA content and S-phase in childhood STS have a significant prognostic impact. The biological behaviour of RMS can be divided at least into three different categories according to their DNA content. Hyperdiploid RMSs are associated with a more favourable prognosis than diploid/near-diploid or tetraploid/hypertetraploid tumours. Larger studies must be carried out to demonstrate this effect when children have received the same treatment protocol before DNA content and S-phase can be applied to the calculation of risk factors at diagnosis and used as an additional means of stratifying the treatment required.
